Barclays PLC Electro Core, Inc. Transaction History

Barclays PLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$1.19 - $2.06 $346 - $599	-291 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$1.62 - $3.05 $471 - $887	291 New	291 $1,000
Q3 2020 Nov 12, 2020	SELL	$0.8 - $2.33 $2,789 - $8,124	-3,487 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$0.75 - $1.29 $570 - $981	-761 Reduced 17.91%	3,487 $3,000
Q1 2020 May 13, 2020	SELL	$0.33 - $1.62 $2,962 - $14,542	-8,977 Reduced 67.88%	4,248 $4,000
Q4 2019 Feb 10, 2020	BUY	$1.23 - $2.67 $8,129 - $17,646	6,609 Added 99.89%	13,225 $21,000
Q3 2019 Nov 14, 2019	SELL	$1.25 - $5.0 $2,526 - $10,105	-2,021 Reduced 23.4%	6,616 $14,000
Q2 2019 Aug 14, 2019	BUY	$1.65 - $6.72 $2,531 - $10,308	1,534 Added 21.6%	8,637 $18,000
Q1 2019 May 15, 2019	BUY	$4.84 - $9.07 $34,378 - $64,424	7,103 New	7,103 $50,000
Q4 2018 Feb 14, 2019	SELL	$4.21 - $14.28 $9,514 - $32,272	-2,260 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.02 - $17.54 $29,425 - $39,640	2,260 New	2,260 $32,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $798M
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.